Elizabeth TREHU,Richard M. JACK,Richard M. JACK,理查德‧M‧杰克
申请号：
HK18115088
公开号：
HK1256036A1
申请日:
2018.11.26
申请国别(地区):
HK
年份:
2019
代理人:
摘要：
In part, the disclosure relates to methods of treating myeloproliferative disorders by administering one or more Serum Amyloid Protein (SAP) proteins. In certain aspects, the method further comprises monitoring treatment efficacy by measuring change in mutant allele burden. In certain aspects, the disclosure relates to methods of treating myelofibrosis in patient sub-populations who carry myelofibrosis-associated mutations in some of their cells by administering an SAP protein.
